CRMD
CorMedix Inc.
3.59
USD
This page is just a preview of the data found in TrendSpider’s full version
CorMedix Inc. stock is up 11.49% since 30 days ago. The next earnings date is Mar 28, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 42.86% of the previous 13 December’s closed higher than November. In the last 2 Unusual Options Trades, there were 2 PUTs. 100% of analysts rate it a buy.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 11 Oct 17:24 | 17 Nov, 2023 | 3.00 | 202 | ||
| 15 Nov 20:54 | 15 Dec, 2023 | 4.00 | 964 |
CorMedix Inc. focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings.
